ArticleTranslational oncology2019

The Combination of Olaratumab with Doxorubicin and Cisplatinum Regresses a Chemotherapy-Resistant Osteosarcoma in a Patient-Derived Orthotopic Xenograft Mouse Model.

Takashi Higuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.